New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more
A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more" has been published in Oncotarget.
Nov 29, 2022
0
2
A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more" has been published in Oncotarget.
Nov 29, 2022
0
2
Gene variants associated with leukemia can produce "rogue" immune cells that drive autoimmune diseases, according to a new study from the Garvan Institute of Medical Research.
Nov 28, 2022
0
134
As differently as cancers or autoimmune diseases (such as multiple sclerosis, rheumatoid arthritis or psoriasis) affect people, they all have one characteristic in common: they are accompanied by increased cell proliferation. ...
Nov 14, 2022
0
40
The innate immune system fights infectious agents, and the alarm messenger interferon plays a central role in this. However, if interferon is produced in the absence of an infection, it can lead to autoimmune diseases. Researchers ...
Nov 8, 2022
0
28
When your body fights off an infection, you develop a fever. If you have arthritis, your joints will hurt. If a bee stings your hand, your hand will swell up and become stiff. These are all manifestations of inflammation ...
Nov 7, 2022
0
3
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
Nov 5, 2022
0
20
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Nov 3, 2022
0
9
Recent advances in immunotherapy for cancer have stimulated a plethora of studies aimed at developing T cells (white blood cells) and Natural Killer (NK) cells (immune cells with enzymes that can kill tumor cells or cells ...
Nov 3, 2022
0
6
The prognosis for the sick child, who hadn't responded to standard treatment, was dire. But a team of Rutgers physicians believed there might be hope despite the conventional wisdom against pursuing any further treatment.
Oct 27, 2022
0
39
A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting. Moreover, one of the experimental mAbs ...
Oct 27, 2022
0
34